name: bioavailability_ma_et_al
description: |-
  Oral bioavailability is defined as the rate and extent to which the
  active ingredient or active moiety is absorbed from a drug product and becomes
  available at the site of action.
targets:
- id: bioavailable
  description: whether it available at the site of action (1) or not (0)
  units: bioavailable
  type: categorical
  names:
  - Oral bioavailability
  - bioavailability
  - ADME bioavailability
  - Drug delivery
  uris:
  - https://bioportal.bioontology.org/ontologies/NCIT?p=classes&conceptid=http%3A%2F%2Fncicb.nci.nih.gov%2Fxml%2Fowl%2FEVS%2FThesaurus.owl%23C70913
benchmarks:
- name: TDC
  link: https://tdcommons.ai/
  split_column: split
identifiers:
- id: SMILES
  type: SMILES
  description: SMILES
- id: compound_name
  type: Other
  names:
  - drug bank name
  - drug name pubchem
  - drug generic name
  - drug chemical (generic) name
  - chemical name
  description: Drug name
license: CC BY 4.0
links:
- url: https://doi.org/10.1016/j.jpba.2008.03.023
  description: corresponding publication
- url: https://tdcommons.ai/single_pred_tasks/adme/#bioavailability-ma-et-al
  description: data source
num_points: 640
bibtex:
- |-
  @article{Ma2008,
  doi = {10.1016/j.jpba.2008.03.023},
  url = {https://doi.org/10.1016/j.jpba.2008.03.023},
  year = {2008},
  month = aug,
  publisher = {Elsevier BV},
  volume = {47},
  number = {4-5},
  author = {Chang-Ying Ma and Sheng-Yong Yang and Hui Zhang
  and Ming-Li Xiang and Qi Huang and Yu-Quan Wei},
  title = {Prediction models of human plasma protein binding rate and
  oral bioavailability derived by using GA-CG-SVM method},
  journal = {Journal of Pharmaceutical and Biomedical Analysis}
